SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Idenix Pharmaceuticals (IDIX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: DewDiligence_on_SI5/4/2010 8:49:12 AM
   of 412
 
IDIX ‘ReadMeFirst’ updated:

all-oral HCV cocktail of IDX184+IDX320;
2010-2011 news flow;
Thomas Weisel raises price target to $9;
1Q10 financial results;
liquidity and cash usage;
transcript of 1Q10 CC;
latest financing transaction;
updated share count for valuation purposes;
guessing the milestone payments from GSK (revised for $6.5M receipt);
new version of “HCV: Most Likely to Succeed.”

siliconinvestor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News